Fuente: WIPO "tomato" The invention relates to modified or unmodified Peptidylglycine a-amidating monooxygenase (PAM) or fragments thereof for use in the treatment or prevention of cerebral hypoperfusion in a subject in need thereof for the improvement of cerebral blood flow (CBF), as well as to corresponding pharmaceutical formulations and kits.